Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15738952 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Combination or Sequential Therapy of Peginterferon Alfa-2a and Entecavir for Patients With Chronic Hepatitis B
Condition: Chronic Hepatitis B
Interventions: Drug: Peg-IFNα-2a;   Drug: Entecavir

Indicates status has not been verified in more than two years